FDA Orange Book
Generic for Verelan
Verelan contains verapamil. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Verelan is verapamil. 1 company holds an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB. Generics match 3 of the 4 Verelan products the Orange Book lists.
Run it in Rivvi
Map Verelan and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Verelan products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| capsule, extended release, oral | 120MG | Marketed (Rx) | AB | 1 | AB |
| capsule, extended release, oral | 180MG | Marketed (Rx) | AB | 1 | AB |
| capsule, extended release, oral | 240MG | Marketed (Rx) | AB | 1 | AB |
| capsule, extended release, oral | 360MG | Marketed (Rx) | None | 0 | None |
NDA 019614, held by AZURITY PHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic verapamil
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| MYLAN PHARMACEUTICALS INC | 075138 | AB (A-rated, therapeutically equivalent) | April 20, 1999 | 120MG, 180MG, 240MG |
Verelan NDC codes
Questions
Is there a generic for Verelan?
Yes. The generic name for Verelan is verapamil. 1 company holds an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB. Generics match 3 of the 4 Verelan products the Orange Book lists.
What is the generic name for Verelan?
The active ingredient in Verelan is verapamil, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.